Aaron Kimson
Stock Analyst at Citizens JMP
(3.03)
# 2,623
Out of 4,646 analysts
94
Total ratings
52.9%
Success rate
4.2%
Average return
Main Sectors:
Stocks Rated by Aaron Kimson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXFY Expensify | Upgraded: Buy | $3 | $2.22 | +35.14% | 13 | Aug 7, 2026 | |
| HNGE Hinge Health | Maintained: Buy | $96 → $107 | $87.42 | +22.40% | 5 | Aug 5, 2026 | |
| PBI Pitney Bowes | Maintained: Buy | $19 → $22 | $16.65 | +32.13% | 5 | Jul 31, 2026 | |
| GWRE Guidewire Software | Maintained: Buy | $300 → $220 | $182.62 | +20.47% | 14 | Jun 5, 2026 | |
| NCNO nCino | Maintained: Buy | $32 → $23 | $20.66 | +11.33% | 16 | May 18, 2026 | |
| BLND Blend Labs | Maintained: Buy | $5 → $4 | $1.55 | +158.06% | 9 | May 8, 2026 | |
| PCOR Procore Technologies | Upgraded: Buy | $71 | $62.17 | +14.20% | 15 | Apr 29, 2026 | |
| PHR Phreesia | Downgraded: Hold | n/a | $12.62 | - | 10 | Apr 1, 2026 | |
| EQPT EquipmentShare.com | Initiated Coverage: Buy | $42 | $21.41 | +96.17% | 1 | Feb 17, 2026 | |
| EVCM EverCommerce | Reiterated: Buy | $15 | $10.11 | n/a | 6 | May 12, 2025 |
Expensify
Aug 7, 2026
Upgraded: Buy
Price Target: $3
Current: $2.22
Upside: +35.14%
Hinge Health
Aug 5, 2026
Maintained: Buy
Price Target: $96 → $107
Current: $87.42
Upside: +22.40%
Pitney Bowes
Jul 31, 2026
Maintained: Buy
Price Target: $19 → $22
Current: $16.65
Upside: +32.13%
Guidewire Software
Jun 5, 2026
Maintained: Buy
Price Target: $300 → $220
Current: $182.62
Upside: +20.47%
nCino
May 18, 2026
Maintained: Buy
Price Target: $32 → $23
Current: $20.66
Upside: +11.33%
Blend Labs
May 8, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $1.55
Upside: +158.06%
Procore Technologies
Apr 29, 2026
Upgraded: Buy
Price Target: $71
Current: $62.17
Upside: +14.20%
Phreesia
Apr 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $12.62
Upside: -
EquipmentShare.com
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $21.41
Upside: +96.17%
EverCommerce
May 12, 2025
Reiterated: Buy
Price Target: $15
Current: $10.11
Upside: n/a